Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Klinique Medical Clinic PCL (BKK:KLINIQ) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
The Klinique Medical Clinic PCL Forward PE Ratio Related Terms
The Klinique Medical Clinic PCL Forward PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Klinique Medical Clinic PCL Forward PE Ratio Chart
The Klinique Medical Clinic PCL Annual Data
Trend
2024-12
2025-12
Forward PE Ratio
19.29
12.11
The Klinique Medical Clinic PCL Quarterly Data
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
19.29
18.10
14.39
15.19
12.11
13.20
BKK:KLINIQ vs ROL, SCI, HRB: Forward PE Ratio Comparison
For the Personal Services subindustry, The Klinique Medical Clinic PCL's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Klinique Medical Clinic PCL Forward PE Ratio vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, The Klinique Medical Clinic PCL's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where The Klinique Medical Clinic PCL's Forward PE Ratio falls into.
The Klinique Medical Clinic PCL Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
The Klinique Medical Clinic PCL (BKK:KLINIQ) has a Forward PE Ratio of 16.06 as of Aug. 03, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on The Klinique Medical Clinic PCL and its competitors. According to the industry distribution chart, The Klinique Medical Clinic PCL ranks #25 out of 36 companies in the Personal Services industry, placing it in the top 69.4%.
Is The Klinique Medical Clinic PCL's Forward PE Ratio too high?
The Klinique Medical Clinic PCL's current Forward PE Ratio is 16.06. The Personal Services industry median Forward PE Ratio is 12.54. The Klinique Medical Clinic PCL's value of 16.06 is 28.1% above this industry median. Based on the distribution chart, The Klinique Medical Clinic PCL ranks #25 out of 36 companies in the Personal Services industry, which is below the industry midpoint. Overall, The Klinique Medical Clinic PCL has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Klinique Medical Clinic PCL's Forward PE Ratio compare to ROL and SCI?
According to the Personal Services industry distribution chart, The Klinique Medical Clinic PCL ranks #25 out of 36 companies for Forward PE Ratio. This places The Klinique Medical Clinic PCL in the lower half of its industry. The industry median Forward PE Ratio is 12.54. The Klinique Medical Clinic PCL's value of 16.06 is 28.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Personal Services company?
The median Forward PE Ratio among Personal Services companies is 12.54, based on 36 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Klinique Medical Clinic PCL's current Forward PE Ratio of 16.06 is 28.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on The Klinique Medical Clinic PCL and its competitors. For the Personal Services industry, the median Forward PE Ratio is 12.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Klinique Medical Clinic PCL's current Forward PE Ratio is 16.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Klinique Medical Clinic PCL stock overvalued right now?
Based on GuruFocus' analysis, The Klinique Medical Clinic PCL (BKK:KLINIQ) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿44.59, compared to a current price of ฿28.00 — trading 37.2% below its estimated fair value. The current Forward PE Ratio is 16.06 and 28.1% above the Personal Services industry median of 12.54. The Klinique Medical Clinic PCL's overall GF Score™ is 90/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For The Klinique Medical Clinic PCL (BKK:KLINIQ), the current Forward PE Ratio is 16.06 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Klinique Medical Clinic PCL (BKK:KLINIQ) Overvalued in 2026?
Based on GuruFocus' analysis, The Klinique Medical Clinic PCL stock appears to be undervalued.
The current stock price of ฿28.00 is trading 37.2% below its estimated GF Value™ of ฿44.59.
GuruFocus considers The Klinique Medical Clinic PCL to be Significantly Undervalued.
Key valuation signals for BKK:KLINIQ:
Forward PE Ratio: 16.06
GF Value™: ฿44.59 vs. price of ฿28.00 (37.2% below fair value)
Industry Position: 28.1% above the Personal Services median (#25 of 36)
No single metric tells the full story. See the BKK:KLINIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Klinique Medical Clinic PCL provides skin care services, beauty, skin care, body contouring, and surgery. including providing holistic care services. The company has a wide range of services and products to meet the needs of customers at all levels, such as facial treatment services, reducing redness, reducing dark spots, laser services for face lifting, face reshaping, skin care, Body shape by removing and dissolving fat, cosmetic surgery, etc. In addition, the company also sells cosmeceuticals. There are various types of products, such as Special Care, Clean & Prepare, Whitening Set, Sun Care, and Antioxidant. The group operates two core business segments: Skin medical services and distribution of cosmetics and medical cosmetics; and Surgery services.
90GF Score
Get the complete analysis for BKK:KLINIQ
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:KLINIQ has been successfully added to your 
